内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Ambaw Bellete. Insider active across 1 company, notably CG Oncology, Inc.. In total, 20 filings have been recorded. Activity tracked since 15 July 2026. The latest transaction was filed on 11 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ambaw Bellete
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
826 股@ US$75.00CommonSEC144:0001950047-26-009375
50,000 股@ US$75.5050.057% mcap6.9% 占其流量CommonSEC144:0001950047-26-008873
5,789 股@ US$79.38520.0066% mcap0.9% 占其流量CommonSEC144:0001950047-26-008793
10,551 股@ US$79.55060.012% mcap1.7% 占其流量CommonSEC144:0001950047-26-008678
5,762 股@ US$79.51840.0066% mcap0.9% 占其流量CommonSEC144:0001950047-26-008634
100,000 股@ US$79.54110.12% mcap16.2% 占其流量CommonSEC144:0001950047-26-008371
52,438 股@ US$76.9460.061% mcap9.8% 占其流量CommonSEC144:0001950047-26-008205
19,364 股@ US$75.01730.022% mcap3.9% 占其流量CommonSEC144:0001950047-26-008191
25,989 股@ US$75.95410.030% mcap5.6% 占其流量CommonSEC144:0001950047-26-008109
32,137 股@ US$78.6170.037% mcap7.6% 占其流量CommonSEC144:0001950047-26-008043
50,000 股@ US$76.20510.056% mcap12.3% 占其流量CommonSEC144:0001950047-26-007989
50,000 股@ US$75.41160.056% mcap13.9% 占其流量CommonSEC144:0001950047-26-007845
9,250 股@ US$75.250.011% mcap3.0% 占其流量CommonSEC144:0001950047-26-007823
75,000 股@ US$75.62950.089% mcap25.0% 占其流量CommonSEC144:0001950047-26-007736
25,000 股@ US$73.500.029% mcap10.8% 占其流量CommonSEC144:0001950047-26-007711
4,303 股@ US$73.500.0050% mcap2.1% 占其流量CommonSEC144:0001950047-26-007416
50,000 股@ US$72.50390.057% mcap24.8% 占其流量CommonSEC144:0001950047-26-007370
50,000 股@ US$72.55990.059% mcap32.9% 占其流量CommonSEC144:0001950047-26-007310
50,000 股@ US$71.77240.057% mcap48.5% 占其流量CommonSEC144:0001950047-26-007270
52,438 股@ US$72.77180.059% mcap100.0% 占其流量CommonSEC144:0001950047-26-007109
About Ambaw Bellete
AMBAW BELLETE is a declarant linked to CG Oncology, Inc. as an Officer. He has 9 filings in total, and across the 9 recent filings available, they all concern sales, with a combined amount of EUR 23488557 between 2026-07-15 and 2026-08-10. The most common transaction type is Notice of proposed sale (Form 144).